Efficacy, safety, and tolerability of chenodeoxycholic acid (CDCA) in adult patients with cerebrotendinous xanthomatosis (RESTORE): A randomized withdrawal, double-blind, placebo-controlled, crossover phase-3 study US$ 29.81 Min. order: 1 piece ★★★★★ 4.7 (170 reviews) Sold : Login>>
New compound stops progressive kidney disease in its tracks US$ 28.28 Min. order: 1 piece ★★★★★ 4.1 (299 reviews) Sold : Login>>
Unlocking Healing Potential: Benefits of BPC-157 Peptide Therapy US$ 23.78 Min. order: 1 piece ★★★★★ 5.0 (105 reviews) Sold : Login>>